Literature DB >> 21987028

Balcova heart study: rationale and methodology of the Turkish cohort.

Gül Ergör1, Ahmet Soysal, Kaan Sözmen, Belgin Ünal, Reyhan Uçku, Bülent Kılıç, Türkan Günay, Alp Ergör, Yücel Demiral, Gül Saatlı, Reci Meseri, Hakan Baydur, Hatice Simşek, Refik Budak, Hale Arık, Nuriye Karakuş.   

Abstract

OBJECTIVES: Turkey is facing increasing rates of cardiovascular disease (CVD). The study is designed to meet the growing need to obtain information about the recent status and trends of CVD risk factors and their impact on mortality.
METHODS: Balcova heart study (BHS) is a prospective cohort study, focusing on reducing the CVD risk factors of people over 30 years old living in Balcova District, Izmir, Turkey. Information about risk factors, anthropometric and biochemical measurements was collected in community centers. Interventions were planned, based on the 10-year coronary heart disease (CHD) risk and lifestyle characteristics with the collaboration of university and municipality.
RESULTS: Mean age of the 16,080 participants was 52 years. The percentage of current smoking was 41.6 in men and 31.1 in women. One-third of the men were physically inactive. Hypertension was reported as 25% in men and 33% in women.
CONCLUSIONS: The project is unique for being the first community-based cohort on CVD risk factors in a Turkish setting. This project will have a valuable contribution on not only determining CVD risks, but also incorporating interventions for prevention.

Entities:  

Mesh:

Year:  2011        PMID: 21987028     DOI: 10.1007/s00038-011-0309-x

Source DB:  PubMed          Journal:  Int J Public Health        ISSN: 1661-8556            Impact factor:   3.380


  23 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alex Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; Mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

3.  Cardiovascular disease in Europe.

Authors:  Mike Rayner; Steven Allender; Peter Scarborough
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-08

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; M Mähönen; H Tolonen; E Ruokokoski; P Amouyel
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

Review 6.  Risk factors and cardiovascular disease in Turkey.

Authors:  A Onat
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

7.  Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.

Authors:  Aytekin Oğuz; Ahmet Temizhan; Adnan Abaci; Omer Kozan; Cetin Erol; Zeki Ongen; Sükrü Celik
Journal:  Anadolu Kardiyol Derg       Date:  2008-12

8.  Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.

Authors:  R W Mahley; K E Palaoğlu; Z Atak; J Dawson-Pepin; A M Langlois; V Cheung; H Onat; P Fulks; L L Mahley; F Vakar
Journal:  J Lipid Res       Date:  1995-04       Impact factor: 5.922

9.  Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP).

Authors:  Ilhan Satman; Temel Yilmaz; Ahmet Sengül; Serpil Salman; Fatih Salman; Sevil Uygur; Irfan Bastar; Yildiz Tütüncü; Mehmet Sargin; Nevin Dinççag; Kubilay Karsidag; Sibel Kalaça; Cihangir Ozcan; Hilary King
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

10.  Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey.

Authors:  S Yavuz Sanisoglu; Cagatay Oktenli; Adnan Hasimi; Mehmet Yokusoglu; Mehmet Ugurlu
Journal:  BMC Public Health       Date:  2006-04-10       Impact factor: 3.295

View more
  8 in total

1.  Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation.

Authors:  Majid Ghayour-Mobarhan; Mohsen Moohebati; Habibollah Esmaily; Mahmoud Ebrahimi; Seyed Mohammad Reza Parizadeh; Ali Reza Heidari-Bakavoli; Mohammad Safarian; Naghmeh Mokhber; Mohsen Nematy; Hamidreza Saber; Maryam Mohammadi; Mohammad Sobhan Sheikh Andalibi; Gordon A Ferns; Mahmoud Reza Azarpazhooh
Journal:  Int J Public Health       Date:  2015-05-06       Impact factor: 3.380

2.  Prevalence of Metabolic Syndrome and Affecting Factors among Individuals Aged 30 and over in Balçova District of İzmir.

Authors:  Ahmet Soysal; Hatice Şimşek; Sinem Doğanay; Türkan Günay
Journal:  Balkan Med J       Date:  2016-05-01       Impact factor: 2.021

3.  On the Severity of Carpal Tunnel Syndrome: Diabetes or Metabolic Syndrome.

Authors:  Fatma Gül Yurdakul; Hatice Bodur; Özgür Öztop Çakmak; Can Ateş; Filiz Sivas; Filiz Eser; Özlem Yılmaz Taşdelen
Journal:  J Clin Neurol       Date:  2015-07       Impact factor: 3.077

4.  Socioeconomic Inequalities in Non-Communicable Diseases and Self Assessed Health in Turkey.

Authors:  Kaan Sozmen; Belgin Unal
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

5.  Evaluating the Relationship between Diabetes and Cancer in a Cohort.

Authors:  Simge Ruhiye Yilmaz Kavcar; Ayla Acikgoz; Gul Ergor; Belgin Unal
Journal:  Asian Pac J Cancer Prev       Date:  2022-04-01

6.  Research capacity and training needs for non-communicable diseases in the public health arena in Turkey.

Authors:  Bulent Kilic; Peter Phillimore; Duygu Islek; Dilek Oztoprak; Eren Korkmaz; Niveen Abu-Rmeileh; Shahaduz Zaman; Belgin Unal
Journal:  BMC Health Serv Res       Date:  2014-09-05       Impact factor: 2.655

7.  Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008.

Authors:  Belgin Unal; Kaan Sözmen; Hale Arık; Gül Gerçeklioğlu; Deniz Utku Altun; Hatice Şimşek; Sinem Doganay; Yücel Demiral; Özgür Aslan; Kathleen Bennett; Martin O'Flaherty; Simon Capewell; Julia Critchley
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295

8.  Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study.

Authors:  Ceyda Sahan; Kaan Sozmen; Belgin Unal; Martin O'Flaherty; Julia Critchley
Journal:  BMJ Open       Date:  2016-07-07       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.